These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Endothelial Heterogeneity in the Response to Autophagy Drives Small Vessel Muscularization in Pulmonary Hypertension. Zhang Q; Yaoita N; Tabuchi A; Liu S; Chen SH; Li Q; Hegemann N; Li C; Rodor J; Timm S; Laban H; Finkel T; Stevens T; Alvarez DF; Erfinanda L; de Perrot M; Kucherenko MM; Knosalla C; Ochs M; Dimmeler S; Korff T; Verma S; Baker AH; Kuebler WM Circulation; 2024 Aug; 150(6):466-487. PubMed ID: 38873770 [TBL] [Abstract][Full Text] [Related]
44. Absence of the MFG-E8 gene prevents hypoxia-induced pulmonary hypertension in mice. Wang J; Wu J; Zhu X; Chen J; Zhao J; Xu Y; Xie J J Cell Physiol; 2021 Jan; 236(1):587-600. PubMed ID: 32592231 [TBL] [Abstract][Full Text] [Related]
45. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension. Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797 [TBL] [Abstract][Full Text] [Related]
46. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling. Cheng G; Wang X; Li Y; He L Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784 [TBL] [Abstract][Full Text] [Related]
47. Micro-RNA-1 is decreased by hypoxia and contributes to the development of pulmonary vascular remodeling via regulation of sphingosine kinase 1. Sysol JR; Chen J; Singla S; Zhao S; Comhair S; Natarajan V; Machado RF Am J Physiol Lung Cell Mol Physiol; 2018 Mar; 314(3):L461-L472. PubMed ID: 29167124 [TBL] [Abstract][Full Text] [Related]
48. DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy. Ferguson BS; Wennersten SA; Demos-Davies KM; Rubino M; Robinson EL; Cavasin MA; Stratton MS; Kidger AM; Hu T; Keyse SM; McKnight RA; Lane RH; Nozik ES; Weiser-Evans MCM; McKinsey TA Am J Physiol Heart Circ Physiol; 2021 Aug; 321(2):H382-H389. PubMed ID: 34142888 [TBL] [Abstract][Full Text] [Related]
49. Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension. Tang H; Chen J; Fraidenburg DR; Song S; Sysol JR; Drennan AR; Offermanns S; Ye RD; Bonini MG; Minshall RD; Garcia JG; Machado RF; Makino A; Yuan JX Am J Physiol Lung Cell Mol Physiol; 2015 Jan; 308(2):L208-20. PubMed ID: 25416384 [TBL] [Abstract][Full Text] [Related]
50. Critical role of VGLL4 in the regulation of chronic normobaric hypoxia-induced pulmonary hypertension in mice. Tian Q; Fan X; Ma J; Li D; Han Y; Yin X; Wang H; Huang T; Wang Z; Shentu Y; Xue F; Du C; Wang Y; Mao S; Fan J; Gong Y FASEB J; 2021 Aug; 35(8):e21822. PubMed ID: 34314061 [TBL] [Abstract][Full Text] [Related]
51. Involvement of Gax gene in hypoxia-induced pulmonary hypertension, proliferation, and apoptosis of arterial smooth muscle cells. Xia S; Tai X; Wang Y; An X; Qian G; Dong J; Wang X; Sha B; Wang D; Murthi P; Kalionis B; Wang X; Bai C Am J Respir Cell Mol Biol; 2011 Jan; 44(1):66-73. PubMed ID: 20160044 [TBL] [Abstract][Full Text] [Related]
52. Dynamic and diverse changes in the functional properties of vascular smooth muscle cells in pulmonary hypertension. Stenmark KR; Frid MG; Graham BB; Tuder RM Cardiovasc Res; 2018 Mar; 114(4):551-564. PubMed ID: 29385432 [TBL] [Abstract][Full Text] [Related]
53. The association of neuron-derived orphan receptor 1 with pulmonary vascular remodeling in COPD patients. Wang CG; Li C; Lei W; Jiang JH; Huang JA; Zeng DX Int J Chron Obstruct Pulmon Dis; 2018; 13():1177-1186. PubMed ID: 29695901 [TBL] [Abstract][Full Text] [Related]
54. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target. Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330 [TBL] [Abstract][Full Text] [Related]
55. FGF12 (Fibroblast Growth Factor 12) Inhibits Vascular Smooth Muscle Cell Remodeling in Pulmonary Arterial Hypertension. Yeo Y; Yi ES; Kim JM; Jo EK; Seo S; Kim RI; Kim KL; Sung JH; Park SG; Suh W Hypertension; 2020 Dec; 76(6):1778-1786. PubMed ID: 33100045 [TBL] [Abstract][Full Text] [Related]
56. Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment. Veith C; Zakrzewicz D; Dahal BK; Bálint Z; Murmann K; Wygrecka M; Seeger W; Schermuly RT; Weissmann N; Kwapiszewska G Thromb Haemost; 2014 Dec; 112(6):1288-303. PubMed ID: 25231004 [TBL] [Abstract][Full Text] [Related]
57. Neutralization of CXCL12 attenuates established pulmonary hypertension in rats. Bordenave J; Thuillet R; Tu L; Phan C; Cumont A; Marsol C; Huertas A; Savale L; Hibert M; Galzi JL; Bonnet D; Humbert M; Frossard N; Guignabert C Cardiovasc Res; 2020 Mar; 116(3):686-697. PubMed ID: 31173066 [TBL] [Abstract][Full Text] [Related]
58. Deficiency of NOX1/nicotinamide adenine dinucleotide phosphate, reduced form oxidase leads to pulmonary vascular remodeling. Iwata K; Ikami K; Matsuno K; Yamashita T; Shiba D; Ibi M; Matsumoto M; Katsuyama M; Cui W; Zhang J; Zhu K; Takei N; Kokai Y; Ohneda O; Yokoyama T; Yabe-Nishimura C Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):110-9. PubMed ID: 24233492 [TBL] [Abstract][Full Text] [Related]
59. LncRNA-TCONS_00034812 in cell proliferation and apoptosis of pulmonary artery smooth muscle cells and its mechanism. Liu Y; Sun Z; Zhu J; Xiao B; Dong J; Li X J Cell Physiol; 2018 Jun; 233(6):4801-4814. PubMed ID: 29150946 [TBL] [Abstract][Full Text] [Related]